Das maligne Mesotheliom der Pleura
Research output: Contribution to journal › Review article › Contributed › peer-review
Contributors
Abstract
Malignant pleural mesothelioma (MMP) is a highly aggressive tumor arising of the pleural mesothelium. Asbestos exposure is the main factor involved in the pathogenesis of MMP and according to the late ban of this agent in 2005 the peak incidence in Europe is expected in the next twenty years. The highly aggressive behaviour of this tumor results in a poor prognosis with a mean overall survival between 7 and 9 months. Despite the progress made in diagnosis and therapy of this entity the optimal treatment remains a subject of debate. In this article we review the current state of treatment and diagnosis.
Translated title of the contribution | Malignant pleural mesothelioma |
---|
Details
Original language | German |
---|---|
Pages (from-to) | 481-486 |
Number of pages | 6 |
Journal | Deutsche Medizinische Wochenschrift |
Volume | 137 |
Issue number | 10 |
Publication status | Published - 2012 |
Peer-reviewed | Yes |
Externally published | Yes |
External IDs
PubMed | 22374657 |
---|
Keywords
ASJC Scopus subject areas
Keywords
- asbestos, intracavitary intraoperative hyperthermic chemotherapy, mesothelioma, multimodal treatment